Youngy Health Co (300247) Fair Value & Analysis
Consumer Cyclical · CN · Market cap 3.3B CNY
Fair value as of: Jul 9, 2026
From 24 valuation models · updated 32 days ago
Share price +1.9% over the past month.
A solid business, but screening 46% overvalued on our models.
What matters now
- A high-quality business (quality 71/100), yet the market already pays well above fair value. Quality at a full price, with little margin of safety.
- The price sits above even our optimistic bull case (¥2.56). The favourable scenario is already priced in.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 9, 2026.
How to read this chart
60‑month range ¥2.33 – ¥5.57 · fair‑value band ¥1.54 – ¥2.56 · the ¥3.79 price screens above the ¥2.05 fair value. Dashed = 300-day average. As of Jul 9, 2026.
Analysis
Youngy Health Co (300247) currently trades at ¥3.79, while our model-based Fair Value estimate is ¥2.05, implying the stock looks roughly 45.9% overvalued today. The Quality Score stands at 71/100 (solid quality), in the Consumer Cyclical sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: medium).
Over the trailing twelve months, Youngy Health Co generated revenue of 921M CNY at a net margin of 7.3%. Revenue declined 4.7% year over year. It earns a return on equity of 8.3%. The balance sheet holds a net cash position of 175M CNY. Fundamentals as of Jul 9, 2026
Our scenario range runs from ¥1.54 (bear case) to ¥2.56 (bull case); at ¥3.79, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 37% below its 52-week high and 4% above its 52-week low, currently below its 200-day average. For context, the median of 10 Consumer Cyclical peers we cover trades at 16% fair-value upside, at -46%, 300247 screens richer than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 24 models by family
Widest divergence: DCF Models (¥2.96) versus Asset-Based (¥0.9500). Highest evidence: Growth DCF (80).
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Jul 9, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 69 · Market factors (momentum, volatility) 36
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Youngy Health Co., Ltd. engages in the manufacture, export, and sale of sauna products in China. Its products include traditional, foot, portable steam, and infrared sauna products, as well as air purifiers. The company also offers carbon heating painting products, functional sofas and chairs, saunalux, and SUP and boat products. It exports its products.
Full company description
Youngy Health Co., Ltd. engages in the manufacture, export, and sale of sauna products in China. Its products include traditional, foot, portable steam, and infrared sauna products, as well as air purifiers. The company also offers carbon heating painting products, functional sofas and chairs, saunalux, and SUP and boat products. It exports its products. The company was founded in 1995 and is headquartered in Hefei, China.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Youngy Health Co reported revenue of ¥933M in FY2025 versus ¥527M in FY2021, a compound +15.4%/yr. Reported net income was ¥74.8M in FY2025, compounding +32.6%/yr from FY2021.
300247 screens 46% overvalued. Compare with Midea Group →
Peer Group
Furnishings, Fixtures & Appliances · 311 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Furnishings, Fixtures & Appliances median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
VALUE 0: the price sits above our fair-value range.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Furnishings, Fixtures & Appliances stocks, each showing price versus our Fair Value estimate (as of Jul 9, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Midea Group 000333 | ¥82.71 | ¥107.22 | +30% |
| Gree Electric Appliances, Inc 000651 | ¥38.25 | ¥88.02 | +130% |
| Haier Smart Home Co 600690 | ¥21.46 | ¥36.04 | +68% |
| King Slide Works Co 2059 | 8,655 TWD | 1,917 TWD | -78% |
| Guangdong Songfa Ceramics Co 603268 | ¥155.59 | ¥38.95 | -75% |
| SharkNinja, Inc SN | $154.53 | $89.07 | -42% |
| Hisense Home Appliances Group 000921 | ¥26.33 | ¥48.03 | +82% |
| Zhejiang Supor Co 002032 | ¥43.85 | ¥44.84 | +2% |
| COWAY Co 021240 | 96,700 KRW | 112,530 KRW | +16% |
| Ecovacs Robotics Co 603486 | ¥50.13 | ¥54.11 | +8% |
Compare Youngy Health Co with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Consumer Cyclical stocks →
Frequently asked questions
Is Youngy Health Co (300247) overvalued or undervalued?
What is the fair value of 300247?
What is the quality score of 300247?
What is the revenue of Youngy Health Co (300247)?
What is the net profit margin of 300247?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Youngy Health Co and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.